Cancer Research UK’s vision is to bring forward the day when all cancers are cured.
Over the last 40 years, cancer survival rates in the UK have doubled. In the 1970s just a quarter of people survived. Today that figure is half.
Cancer Research UK’s ambition is to accelerate progress and see three-quarters of patients surviving the disease within the next 20 years.
Cancer Research UK will achieve its ambitions through a substantial increase in research in priority areas over the next several years:
- – Substantially increase investment to support the earlier diagnosis of cancer
- – Increase investment two- to threefold over the next five years in lung, pancreatic, oesophageal cancers and brain tumours
- – Continue to invest heavily to understand better what causes and drives cancer and the role of the immune system, including through the establishment of the Francis Crick Institute
- – Increase investment in prevention research, including a new centre to support long-term reduction in cancer incidence and continued work on tobacco control
- – Continue to discover and develop new therapeutics, surgery and radiotherapy treatments, including increased investment in biological therapies
- – Optimise the chance of survival for every individual, through precision medicine approaches
To deliver these priorities, Cancer Research UK will:
- – Significantly increase investment through funding committees and launch at least four new funding schemes, including a set of grand challenges to address the major questions
- – Invest heavily in our Centres as a world-class network for the translation of cancer research for patient benefit
- – Encourage collaborative approaches,
seeking to increase international partnership and the involvement of non-traditional cancer disciplines, such as engineering and the
- – Support and develop the very best researchers, at all stages of their careers